References
- 1. Wedon D, Marks R, Kao GF, Harwood CA: Keratinocytic tumours. In: World Health Organisation Classification of Tumours (ed): Pathology and genetics of skin Tumours. IARC Press, Lyon, 2006; 10-48.
- 2. Bumpous J. Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes. Curr Opin Otolaryngol Head Neck Surg. 2009, 17(2):122-5.)10.1097/MOO.0b013e32832924e0
- 3. De Grujil FR, Norval M, Cullen AP, Slaper H, Kripke ML, vander Leun JC: Health effects from stratosphericozone depletion and interactions with climate change. Photochem Photobiol Sci, 2003, 2:16-28.;
- 4. Reichrath J, Rass K. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update Adv Exp Med Biol. 2014;810:208-33.
- 5. Sadamori N, Mine M, Honda T: Incidence of skin cancer among Nagasaki atomic bomb survivors. J Rad Res Tokyo;1991, 2:217-225)
- 6. Marehbian J, Colt JS, Baris D, Stewart P, Stukel TA, Spencer SK, Karagas MR. Occupation and keratinocyte cancer risk: a population-based case-control study. Cancer Causes Control. 2007, 18(8):895-908
- 7. Lau P, Li Chang HH, Gomez JA, Erdeljan P, Srigley JR, Izawa JI. A rare case of carcinoma cuniculatum of the penis in a 55-year-old. Can Urol Assoc J. 2010;4(5):E129-32.
- 8. Ackerman AB: The major types of squamous cell carcinoma. Dermatovenerology, practica & conceptual, 2001, 5:250-252.
- 9. Emmert S, Schön MP, Haenssle HA. Molecular biology of basal and squamous cell carcinomas. Adv Exp Med Biol. 2014;810:234-52.
- 10. Kubo Y, Murao K, Matsumoto K, Arase S: Molecular carcinogenesis of squamous cell carcinomas of the skin. J Med Invest; 2002, 49:111-117.
- 11. Lazarov M, Kubo Y, Cai T, Dajee M, Tarutani M, Lin Q, Fang M, Tao S, Green CL, Khavari PA. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nat Med. 2002;8(10):1105-1114
- 12. Tomas D: Apoptosis, UV-radiation, precancerosis and skin tumors.. Acta Med Croatica. 2009;63 Suppl 2:53-8.
- 13. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of gene for human p53 tumour antigen to band 17p13. Nature 1986; 320:84–5.
- 14. Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007; 26:2157–65.
- 15. Mouton PR: Unbiased Stereology: A Concise Guide. Baltimore John Hopkins University Press, 2011, first edition, pp1-171
- 16. Stratigos AJ, Kapranos N, Petrakou E, Anastasiadou A, Pagouni A, Christofidou E, Petridis A, Papadopoulos O, Kokka E, Antoniou C, Georgala S, Katsambas AD. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation. J Eur Acad Dermatol Venereol, 2005, 19(2):180–186.
- 17. Marinescu A, Stepan AE, Margaritescu C, Marinescu AM, Zavoi RE, Simionescu CE, Niculescu M. P53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions. Rom J Morphol Embryol. 2016;57(2 Suppl):691-696.
- 18. Soussi T, Asselain B, Hamroun D, Kato S, Ishioka C, Claustres M, Béroud C. Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection. Clin Cancer Res. 2006; 12(1):62-9.
- 19. Edlund K, Larsson O, Ameur A, Bunikis I, Gyllensten U, Leroy B, Sundström M, Micke P, Botling J, Soussi T. Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors. Proc Natl Acad Sci U S A. 2012; 109(24):9551-6.
- 20. Naruke Y, Nakashima M, Suzuki K, Kondo H, Hayashi T, Soda M, Sekine I. Genomic instability in the epidermis induced by atomic bomb (A-bomb) radiation: a long-lasting health effect in A-bomb survivors. Cancer. 2009;115(16):3782-90
- 21. Queille S, Luron L, Spatz A, Avril MF, Ribrag V, Duvillard P, Hiesse C, Sarasin A, Armand JP, Daya-Grosjean L. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene. Carcinogenesis. 2007 Mar;28(3): 724-31.
- 22. Karagece Yalçin U, Seçkın S. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases. Turk Patoloji Derg. 2012;28(2):119-27
- 23. Park H-R, Min SK, Cho HD, Kim KH, Shin HS, Park YE. Expression profiles of p63, p53, surviving and hTERT in skin tumors. J Cutan Pathol. 2004;31:544-9.10.1111/j.0303-6987.2004.00228.x
- 24. Dornelas MT, Rodrigues MF, Machado DC, Gollner AM, Ferreira AP. Expression of cell proliferation and apoptosis biomarkers in skin spinocellular carcinoma and actinic keratosis. An Bras Dermatol. 2009;84(5):469-75.10.1590/S0365-05962009000500004
- 25. Khodaeiani E, Fakhrjou A, Amirnia M, Babaei-Nezhad S, Taghvamanesh F, Razzagh-Karimi E, Alikhah H. Immunohistochemical evaluation of p53 and Ki67 expression in skin epithelial tumors. Indian J Dermatol. 2013; 58(3):181-7.
- 26. Lee YS, Teh M. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin. Cancer. 1994; 73(9):2317
- 27. Ruhoy SM, Guinee DG, Nuovo G. Squamous cell carcinoma arising in association with verruca vulgares and HPV-2: a clinicopathologic study with p16 and p53 immunohistochemical studies and human papillomavirus in situ hybridization studies. Appl Immunohistochem Mol Morphol. 2014 Apr;22(4):253-61.
- 28. Drvar DL, Lipozencic J, Sabol I, Mokos ZB, Ilic I, Grce M. Human papillomavirus status in extragenital nonmelanoma skin cancers. Clin Dermatol. 2014 Mar-Apr;32(2):248-5210.1016/j.clindermatol.2013.08.009
- 29. Wood GS, Bagheri M, Gordon E, Larson PO, Snow S : Nonmelanoma skin cancers: basal cell and squamous cell carcinomas. In: Abeloff M, ArmitageJO, Niederhuber JE, Kastan BM, McKenna WG(eds): Clinical Oncology, Elsevier Churchill Livingstone, 2004, 1589-1609
- 30. Opara KO, Jiburum BC. Skin cancers in albinos in a teaching Hospital in eastern Nigeria - presentation and challenges of care. World J Surg Oncol. 2010;8 (73):1-6
- 31. Rodust PM1, Stockfleth E, Ulrich C, Leverkus M, Eberle J. :UV-induced squamous cell carcinoma-a role for antiapoptotic signalling pathways. Br J Dermatol. 2009; 161 Suppl 3:107-1
- 32. Naruke Y, Nakashima M, Suzuki K, Matsuu-Matsuyama M, Shichijo K, Kondo H, Sekine I. : Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability. Cancer Sci. 2008;99(5):946-51.
- 33. Gao L: p53 alterations in human skin. Acta Universitatis Upsaliensis, Uppsala 2001, pp1-53
- 34. Queille S1, Luron L, Spatz A, Avril MF, Ribrag V, Duvillard P, Hiesse C, Sarasin A, Armand JP, Daya-Grosjean L. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene. Carcinogenesis. 2007 Mar;28(3):724-31
- 35. Batinac T, Zamolo G, Jonjic N, Gruber F, Petrovecki M, p53 protein expression and cell proliferation in nonneoplastic and neoplastic proliferative skin diseases, Tumori, 2004, 90(1):120–127
- 36. Sakiz D, Turkmenoglu TT, Kabukcuoglu F. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin. Pathol Res Pract. 2009; 205(9): 589-94.
- 37. Rapini RP:Epithelial neoplasms. In: Rapini RP(ed):Practical Dermatopathology. First edition, Elsevier, 2005, pp 233-25
- 38. KuboY, Murao K, Matsumoto K, Arase S: Molecular carcinogenesis of squamous cell carcinomas of the skin. J Med Invest; 2002, 49:111-117
- 39. Tomas D: Apoptosis, UV-radiation, precancerosis and skin tumors.. Acta Med Croatica. 2009;63 Suppl 2:53-8.
- 40. Nikolic MM: Prekancerozne dermatoze, maligni tumori, pseudoepiteliomske hiperplazije i paraneoplasticne dermatoze. U: Lalevic-Vasic B, Medenica LJ, Nikolic M: Dermatovenerologija sa propedevtikom, Savremena administracija, Beograd, 2008, str 281-299
- 41. Lober BA, Lober CW: Actinic keratosis is squamous cell carcinoma. J Am Acad Dermatol; 2000, 93:650-655
- 42. Gleich T, Chiticariu E, Huber M, Hohl D. Keratoacanthoma: a distinct entity; Exp Dermatol. 2016 Feb; 25(2): 85-9110.1111/exd.12880
- 43. Florence ME, Massuda JY, Soares TC, Stelini RF, Poppe LM, Bröcker EB, Metze K, Cintra ML, de Souza EM. p53 immunoexpression in stepwise progression of cutaneous squamous cell carcinoma and correlation with angiogenesis and cellular proliferation. Pathol Res Pract. 2015 Oct;211(10): 782-8.
- 44. Stratigos AJ, Kapranos N, Petrakou E, Anastasiadou A, Pagouni A, Christofidou E, Petridis A, Papadopoulos O, Kokka E, Antoniou C, Georgala S, Katsambas AD. Immunophenotypic analysis of the p53 gene in nonmelanoma skin cancer and correlation with apoptosis and cell proliferation. J Eur Acad Dermatol Venereol. 2005 Mar;19(2):180-6.
- 45. Khullar G, Saikia UN, De D, Handa S, Das Radotra B. Predisposing factors and histopathological variants of cutaneous squamous cell carcinoma: Experience from a North Indian teaching hospital. Indian J Dermatol Venereol Leprol. 2016 May-Jun;82(3):273-8
- 46. Adinarayan M, Krishnamurthy SP. Clinicopathological evaluation of nonmelanoma skin cancer. Indian J Dermatol 2011;56:670-2